Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT01573780
Previous Study | Return to List | Next Study

Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors

This study has been terminated.
(Sponsor did not have funds to continue study)
National Cancer Institute (NCI)
TetraLogic Pharmaceuticals
Information provided by (Responsible Party):
Roswell Park Cancer Institute Identifier:
First received: March 13, 2012
Last updated: January 14, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)